for Year 2017 Ending 31 December 2017 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 1/2018 dated 24

Advisory Company Limited, an approved financial advisor by The Securities and Exchange Commission, as Independent Financial Advisor to provide opinion regarding the increase investment cost and related party

currency exchange rate and an increase in the cost of goods sold. The higher cost of goods sold was due to an increase in the production of new high-technology products, such as the special grade PCB (HDI

BS09/2545 (Translation) No.18/2019 July 5, 2019 President The Stock Exchange of Thailand Re: Notification of the Resolution of the Board of Directors’ Meeting No. 8/2019 We, AEON Thana Sinsap

หน้าที 1 จาก 5 GEL.CS.019/2560 15 August 2017 Subject Explanation and analysis of management for operating results of the Second Quarter Ended June 30, 2017 To Director and Manager The Stock Exchange

: 0107556000248 No. (SUTHA-SET) 030/2017/Eng 10 November 2017 Subject: Management Discussion and Analysis for period ended 30 September 2017 To: The President of the Stock Exchange of Thailand Attachment

MD&A Eng Q1-19 13-5-19 _1_ 1 Translation UWC 014-2019 May 14, 2019 Subject : Management Discussion and Analysis for quarter 1-2019 To : President of the Stock Exchange of Thailand Ua Withya Public

1 Translation UWC 022-2018 May 14, 2018 Subject : Management Discussion and Analysis for quarter 1-2018 To : President of the Stock Exchange of Thailand Ua Withya Public Company Limited ("Company

(Translation) NEP-AC 002/2561 9 August 2018 Subject : Management Discussion and Analysis for 2nd Quarter ended 30 June 2018 To : The President The Stock Exchange of Thailand Operating Result NEP

MD&A Q.2'18EN 1 RP-AC 003/201 AUGUST 1, 201 Subject: Clarification of the operating results for the second quarter of 2018 To: Directors and Managers of the Stock Exchange of Thailand Richy Place